- Home
- ONCY vs ERNA Comparison
ONCY vs ERNA Comparison
Compare ONCY & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- ERNA
- Stock Information
- Founded
- ONCY 1998
- ERNA 2018
- Country
- ONCY Canada
- ERNA United States
- Employees
- ONCY N/A
- ERNA N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- ERNA Health Care
- Exchange
- ONCY Nasdaq
- ERNA Nasdaq
- Market Cap
- ONCY 56.2M
- ERNA 22.6M
- IPO Year
- ONCY 1999
- ERNA N/A
- Fundamental
- Price
- ONCY $0.69
- ERNA $0.35
- Analyst Decision
- ONCY Strong Buy
- ERNA
- Analyst Count
- ONCY 2
- ERNA 0
- Target Price
- ONCY $4.00
- ERNA N/A
- AVG Volume (30 Days)
- ONCY 2.6M
- ERNA 31.3M
- Earning Date
- ONCY 03-06-2025
- ERNA 03-13-2025
- Dividend Yield
- ONCY N/A
- ERNA N/A
- EPS Growth
- ONCY N/A
- ERNA N/A
- EPS
- ONCY N/A
- ERNA N/A
- Revenue
- ONCY N/A
- ERNA $598,000.00
- Revenue This Year
- ONCY N/A
- ERNA N/A
- Revenue Next Year
- ONCY N/A
- ERNA N/A
- P/E Ratio
- ONCY N/A
- ERNA N/A
- Revenue Growth
- ONCY N/A
- ERNA 1072.55
- 52 Week Low
- ONCY $0.67
- ERNA $0.22
- 52 Week High
- ONCY $1.53
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- ONCY 34.93
- ERNA 44.00
- Support Level
- ONCY $0.67
- ERNA $0.33
- Resistance Level
- ONCY $0.72
- ERNA $0.62
- Average True Range (ATR)
- ONCY 0.05
- ERNA 0.09
- MACD
- ONCY -0.01
- ERNA -0.01
- Stochastic Oscillator
- ONCY 9.48
- ERNA 7.32
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.